Contract Manufacturing in Pharmaceutical Industry, 2015-2025 - North America and Europe are the predominant regions where majority of the production facilities of CMOs are located

 

Dublin, Nov. 11, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/lbq8h6/contract) has announced the addition of the "Contract Manufacturing in Pharmaceutical Industry, 2015-2025" report to their offering.

The "Contract Manufacturing in Pharmaceutical Industry, 2015 - 2025" report provides an extensive study of the rapidly growing pharmaceutical contract manufacturing market. With pharmaceutical and biotechnology industry striving to minimize costs and maximize profits, outsourcing has emerged as an ever increasing trend. The study presents an in-depth analysis of a diverse set of CMOs on some of the key parameters such as type of business operation, scale of operation, packaging form, geographical location and range of services. In addition, it captures some of the key growth areas which will likely present tremendous opportunities for CMOs and ensure an accelerated pace of growth. Some of the potential growth areas include biopharmaceutical and high potency manufacturing. Specifically, in these markets, complex manufacturing requirements and capital intensive nature of the business make outsourcing an attractive option.

The market has witnessed several major trends that have governed the evolution of contract manufacturing over the past few years. One of the most significant changes in the outsourcing space is the emergence of strategic contract manufacturing. The conventional model of contract manufacturing involved a vendor-customer equation. However, phasing out that traditional concept, contract manufacturers nowadays believe in entering in strategic alliances with CMO partners with the objective of cutting down production cost and enhancing product pipelines.

The report assesses some of the key drivers that have governed the evolution of contract manufacturing market over the past several years along with an elaborate discussion on the future trends that will shape the market in the coming years. One of the focus areas of this study is to estimate size of the future opportunity in the pharmaceutical contract manufacturing market over the next decade, segmented on the basis of business operations and key regions.

In addition to some of the well-known benefits and a promising outlook, the study also highlights considerable challenges currently prevalent in the market. Examples include quality concerns, cultural differences and lack of transparency in the manufacturing process. Nevertheless, these challenges are paving the way for new strategies and technological improvements, which will indeed be advantageous in the long run.

The base year for the report is 2014; the report provides market forecasts for the period 2015 - 2025. The research, analysis and insights presented in this report is backed by a deep understanding of key insights gathered both from secondary and primary research.

Highlights

- North America and Europe are the predominant regions where majority of the production facilities of CMOs are located. Out of 509 CMOs we studied, 189 have presence in multiple locations in the US. In Europe, the other major hub for CMOs, Germany, Italy and the UK have presence of 58, 37 and 32 CMOs respectively. Companies have also gradually moved their focus to developing countries in order to take advantage of the relatively lower costs.
- The market is well distributed between API manufacturers and FDF manufacturers. Within FDF contract manufacturing, solid dose compounds currently dominate the market. However, future growth is likely to be driven by injectables dose manufacturing primarily due to increased focus on complex disease areas and the growing trend of self-administration.
- In terms of analysis by scale of operation, majority of the CMOs have the capability to operate on clinical as well as commercial scale. Out of 394 CMOs evaluated for this exercise, 340 CMOs have the provision for both clinical and commercial stage manufacturing.
- High potency and biopharmaceuticals manufacturing represent a major growth opportunity for CMOs. Owing to the capital intensive nature of the business and complex manufacturing requirements, CMOs have become the preferred manufacturing partners for majority of the pharmaceutical clients.
- The intense competition in the marketplace is driving CMOs to explore innovation aspects such as eClinical systems, cloud based computing and risk monitoring tools to create differentiation. Specifically, for biopharmaceuticals manufacturing, CMOs have started utilizing novel bio-processing services and technologies such as single use bioreactors.
- With respect to the market size, we have estimated the API and FDF contract manufacturing to be worth USD 35 Billion currently. Driven by the increasing trend of outsourcing, we expect the market to grow at an annualized rate of 8.3%.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Introduction

4. Market Overview

5. Emerging Regions in the CMO Market

6. Competitive Landscape

7. Biopharmaceutical Contract Manufacturing

8. Market Size and Forecast

9. Company Profiles

10. Future of the CMO Market

11. Interview Transcripts

12. Conclusion

13. Appendix 1: Tabulated Data

14. Appendix 2: List Of Companies

- 3M Drug Delivery Systems
- 3P Biopharmaceuticals
- A & Z Pharmaceutical
- AAIPharma Services
- Aarti CRAMS (division of Aarti Industries)
- Aarti Drugs
- AbbVie
- ABL, Inc.
- Accra Pac
- Accucaps Industries
- Acino AG
- AcsDobfar Spa
- AdAlta
- Adamas Pharmaceuticals
- Adhesives Research
- Aegerion
- Aenova
- AERAS
- Aesica Pharmaceuticals Limited
- Affinity Life Sciences, Inc.
- Afton Scientific Corporation
- Agennix
- Agno Pharma
- Ajinomoto Althea
- Akorn India Private Limited (Subsidiary of Akorn)
- Akums Drugs and Pharmaceutical Ltd.
- Aland (Jiangsu) Nutraceutical Co., Ltd.
- Aldevron
- Alkermes
- All Chem Laboratories
- Allergy Laboratories
- Almac Pharma
- Alpax Pharmaceuticals
- Alphora Research
- Alps Pharmaceutical
- Amanta Healthcare
- Amatsi
- Ambiopharm
- Amdipharm
- American Antibiotics
- American Peptide Company
- Ami Drugs and Speciality Chemicals
- Amoli Organics
- Ampac Fine Chemicals
- AMRI Inc.
- AMW GmbH
- AMYRA Biotech
- Angelini Pharmaceuticals (ACRAF)
- Anhui Biochem United Pharmaceutical Co., Ltd.
- Ankur Drugs and Pharma Ltd.
- AnqiuLu'an Pharmaceutical
- Apexigen
- API Polpharma
- Apicore Pharmaceuticals (Subsidiary of Apicore US LLC)
- Apiscent Labs
- APL Sweden
- Apotex Fermentation
- Aptuit
- Arbro Pharmaceuticals
- Arch Pharmalabs
- Arevipharma GmbH
- Arvincare
- Asahi Glass Company, Ltd.
- Asahi Kasei Finechem
- Aspen Bad Oldesloe GmbH
- Astimex Pharma
- AstraZeneca
- Asymchem Laboratories
- Athera Biotechnologies
- Atra Pharmaceuticals Ltd.
- Aurobindo Pharma
- AustarPharma
- Austin Pharma(Subsidiary of Cerilliant Corporation)
- AutekBio, Inc.
- Avalanche Biotechnologies
- Avid Bioservices, Inc.
- Avra Laboratories
- Avyukt Pharmaceuticals
- B. Braun Medical
- Bachem
- Banner Pharmacaps
- Batavia Bioservices
- Bausch & Lomb Incorporated
- Bavarian Nordic GmbH
- Baxil Pharma Ltd.
- Baxter BioPharma Solutions
- BCN Peptides SA
- BeiGene Co., Ltd.
- Beijing second Pharmaceutical Co., Ltd.
- Belcher Pharmaceuticals, LLC
- Beltapharm SPA
- Ben Venue Laboratories (Subsidiary of Boehringer Ingelheim)
- Beximco Pharmaceuticals Ltd.
- Bharat Biotech
- BIBITEC GmbH
- Binex Co. Ltd.
- Bio Elpida
- BioferS.p.A
- Biomay AG
- BIOMEVA GmbH
- Bionorica SE
- Bio-Pharm, Inc.
- Biopharmaceutical Development Program - Frederick National Laboratory for Cancer Research (FNLCR)
- BioReliance
- BioSynergy
- Biotechpharma UAB
- Biotika
- Biovectra Inc
- Biovian Ltd.
- BioVolutions
- BioWa, Inc.
- Bluepharma
- Boehringer Ingelheim BioXcellence
- Bristol-Myers Squibb
- Broad Pharmaceutical Co., Ltd.
- C & O Pharmaceutical technology Limited (Subsidiary of Shionogi & Co., Ltd)
- Cadila Pharmaceuticals Limited
- Calyx Chemicals & Pharmaceuticals Limited
- Cambrex
- Capsugel
- Catalent
- Celladon
- Celonic AG
- Cenexi
- Centaur Pharmaceuticals
- Center for Biocatalysis and Bioprocessing, The University of Iowa
- Century Pharmaceuticals Limited
- Cerbios Pharma
- Cevec Pharmaceuticals
- CF Pharma Ltd.
- Chartwell Pharmaceuticals llc
- ChemCon GmbH
- ChemPacific Corporation
- ChemPartner
- Cherokee Pharmaceuticals LLC
- ChifengArker Pharmaceutical Technology Co. Ltd.
- China Chemical & Pharmaceutical Co., Ltd.
- Chiral Biosciences Ltd.
- Chongqing Huapont Pharmaceutical
- Chunghwa Chemical Synthesis & Biotech Co., Ltd.
- Cingulate Therapeutics
- CironPharma
- Cispharma Inc.
- CiVentiChem, LLC
- CMC Biologics
- CMIC CMO ASHIKAGA Co., Ltd.
- Coating Place Inc
- Cobra Biologics
- Cody Laboratories (Subsidiary of Lannett Company)
- Cognate BioServices
- Coldstream Laboratories, Inc.
- Concord Biotech Limited
- Confab Laboratories Inc.
- Contract Coating Inc.
- Contract Pharmacal Corporation
- Cook Pharmica LLC
- Cooper Pharma Ltd.
- Corden Pharma
- CoreRx Inc
- Corium International, Inc.
- Corvette Pharmaceutical Services Group
- Cris Pharma
- Crown Laboratories
- Crucell
- CTC Bio
- CTC Clinical Trial Consultants AB
- CTX Lifesciences Private Limited
- Custom Pharmaceutical Services (CPS), Dr. Reddy's Laboratories
- Cytovance Biologics, Inc.
- Daiichi Fine Chemical Co., Ltd.
- Daito Pharmaceutical Co.,Ltd.
- Dalton Pharma Services
- Delavau LLC
- Delmar Chemicals Inc.
- Delpharm
- Dental Technologies, Inc.
- Development Center for Biotechnology, Taiwan
- Dipharma Francis S.r.l.
- Dishman Contract Researchand Manufacturing Services (CRAMS)
- Divi's Laboratories Limited
- DM Bio (Dong-A meiji)
- Dottikon Exclusive Synthesis AG
- Douglas Manufacturing Limited
- Dow Corning Corporation
- DPT Laboratories, Ltd.
- DPx Holdings
- DSM Pharmaceutical Products
- DuoCort
- Dupen Laboratories Pvt. Ltd.
- Dwarkesh Pharmaceuticals Pvt. Ltd.
- Ei Inc.
- EirGen Pharma Ltd
- Elan plc
- Eli Lilly
- Elite Laboratories, Inc.
- Embio Limited
- Emcure Pharmaceuticals
- Emergent Biosolutions
- Enaltec Labs
- Encap Drug Delivery
- Enrich pharma
- Epic Pharma, LLC
- Eriochem S.A.
- ErregierreSpA
- EsteveQuimica
- Ethypharm
- Euro Vital Pharma GmbH & Co. KG
- Eurogentec Biologics
- Euticals
- Evonik Industries
- Excella GmbH
- Excelvision
- Exela Pharma Sciences
- F.I.S. FabbricaItalianaSintetici
- Famar
- Famy Care Limited
- Fareva
- Farmabios
- Farmaka.s
- Farmhispania, S.A.
- Fermic
- Fermion Oy
- Ferndale Laboratories (Part of Ferndale Pharma Group)
- Fertin Pharma A/S
- Finecure Pharmaceuticals Ltd.
- Flamel Technologies
- Flamingo Pharmaceuticals
- FlammaS.p.A.
- Fleming Laboratories Limited
- Florida Biologix®
- Fluid Energy Processing and Equipment Co
- Fresenius Kabi
- Fujifilm Diosynth Biotechnologies
- Fujimoto Chemicals Co., Ltd. Kinraku Plant
- Fujirebio Europe B.V. (previously Innogenetics)
- Future Pak LTD.
- G&W Laboratories
- Gallus BioPharmaceuticals
- Genmab A/S
- Gland Pharma Limited
- Glatt GmbH
- GlaxoSmithKline Biopharmaceuticals
- Glenmark Pharmaceuticals Limited
- Global Harvest Pharma
- Glochem Industries Limited
- Glycotope Group
- Goodwin Biotechnology, Inc.
- Gordon Laboratories, Inc.
- GP Pharm
- Grand River Aseptic Manufacturing Inc.
- Granules Omnichem JV
- Grindeks
- Groupe PARIMA Inc.
- Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
- Guardian Drug Company
- Hainan Poly Pharm
- Halo Pharmaceutical Inc
- Hanford Pharmaceuticals
- Hangzhou Hysen Pharma Co., Ltd.
- Hangzhou Imaginechem
- Haupt Pharma
- Health Biotech Limited
- Healthy Life Pharma Pvt. Ltd.
- Helios Pharma
- Helsinn Advanced Synthesis SA
- Hetero Drugs Limited
- Hikal Limited
- HolopackVerpackungstechnik GmbH
- HonsonPharmatech group, Ltd.
- Hospira One 2 One
- Hovione
- Hritik Chemical Pvt. Ltd.
- Hubei Biocause Pharmaceutical Co., Ltd
- HUIYU Pharmaceutical
- Hyglos GmbH
- ICROM S.p.A.
- IDT Australia Limited
- IDT Biologika GmbH
- IGI Labs, Inc.
- IMMUNE Pharmaceutical
- ImmuneMed, IncEclipse
- Immunetep
- Ind Swift Laboratories Limited
- Indena
- Index Ventures LLP
- Indoco Remedies Limited
- INFA Group
- Inno Biologics Sdn. Bhd.
- InnovaCaptab
- Innovent Biologics, Inc.
- Intas Pharmaceuticals
- IRIX Manufacturing Inc.
- Irvine Pharmaceutical Services
- Isochem (Subsidiary of Aurelius AG)
- Isofol Medical
- J.B. Chemicals & Pharmaceuticals Ltd.
- Johnson&Johnson
- Jubilant Life Sciences
- KBI BioPharma, Inc.
- Kekule Pharma Limited
- Kemwell Biopharma Private Limited
- Kilitch Drugs Ltd.
- Kongo Chemical Co., Ltd. Head Plant
- Korten
- Krebs Biochemicals& Industries Ltd
- Laurus Labs
- Legochem Biosciences
- LFB Biomanufacturing
- Lipogen
- LOBA FeinchemieGmbh
- Logos pharma
- Long Pharmaceuticals, LLC
- Lonza
- LSNE
- LTS LohmannTherapie-Systeme AG
- Luitpold Pharmaceuticals, Inc.
- Lusomedicamenta
- Lyne Laboratories, Inc.
- Lyra Laboratories
- Mabion
- Macfarlan Smith Limited
- Macleods Pharmaceuticals Limited, Baddi
- Madras Pharmaceuticals
- MakcurLaboratoies Ltd.
- Malladi Drugs & Pharmaceuticals Limited
- Mass Biologics
- McGuff Pharmaceuticals Inc.
- MDC Pharmaceuticals Ltd.
- Medicago
- Medical Products Laboratories, Inc.
- Medichem S.A.
- Mediwin Pharmaceuticals
- Menadiona, S.L.
- Mercator Pharmaceutical Solutions
- Merch& Co.
- Meridian Life Science, Inc.
- Meridian Medicare Ltd.
- Mesoblast Limited
- Metrics Inc.
- MetrochemApi Private Limited
- Micro Labs Limited
- Microchem SRL
- Micro-Macinazione SA
- Micron technologies
- Micron Technologies Ltd
- Micro-Sphere SA
- Microtrol Sterilization Services Private Limited
- Mikart, Inc.
- Milda AG
- MiltenyiBiotec
- Minomic International Limited
- Mipharma Spa
- Mirror Pharmaceuticals LLC
- Mitovie Pharma
- Mnemosyne Pharmaceutical Inc.
- Molecular Partners
- MSD Chibret
- MSN Laboratories Private Limited
- Multi Pack Solutions
- Mycenax
- Mylan Laboratories
- Nakoda Chemicals Limited
- Nanjing Pharmatechs Co., Ltd.
- Nascent Biologics
- Natco Pharma ltd.
- Nectar Lifesciences Limited
- Neos Therapeutics, LP
- Nephron Pharmaceuticals Corporation
- NerPharMaS.r.l.
- Neuland Laboratories Limited
- Nexgen Pharma, Inc.
- Nextar
- Ningbo Renjian Pharmaceutical Group
- Niota Pharmaceuticals, Inc.
- Nippon Rika Co., Ltd.
- Nipro Patch Co., Ltd.
- Nitin Lifesciences Ltd.
- Nivon Specialities
- Norac Pharma
- Normaco
- North Star Processing, LLC.
- Norwegian Institute of Public Health
- Norwich Pharmaceuticals Inc.
- Novartis
- Novasep
- Novel Laboratories, Inc.
- Novozyme
- Nutragen Pharma Private Limited
- Oakwood Laboratories, L.L.C.
- Oasis Laboratories Pvt. Ltd.
- Olainfarm
- Olon, SpA
- Oman Pharmaceutical Products Co. LLC.
- Omega Pharma
- Omnia Biologics
- OncoMed Pharmaceutical
- Oncotec Pharma Produktion GmbH
- Orchid Pharma
- OrexigenTherpeutics, Inc
- OrganicoFeinchemie GmbH Wolfen
- Orient Pharma
- Orion Corporation
- Orofino Pharmaceutical Group
- OSO Bio Pharmaceuticals Manufacturing, LLC
- Oxford BioTherapeutics
- PacificGMP
- Panacea Biotec Limited
- Par Pharmaceutical Inc.
- Parabolic Drugs
- Paragon Bioservices
- Pasteuria Bioscience
- Patheon (unit of DPx Holdings)
- PCAS Finland Oy (Subsidiary of PCAS S.A.)
- Pegasus farmaco India Pvt. Ltd.
- Pfanstiehl, Inc.
- Pfizer CentreSource
- Pharmaceutical Associates, Inc. (Subsidiary of Beach Products)
- Pharmaceutical Manufacturing Research Services, Inc.
- Pharmaceutics International, Inc.
- Pharmacyclics
- PharmAgra Labs
- Pharmanest AB
- Pharmasol Pharmaceuticals
- PharmaZell
- PharmedArtis GmbH
- Phyton Biotech LLC
- Piramal Pharma Solutions
- Pisgah Labs Inc
- Plasmid Factory
- PolyCarbon Industries, Inc.
- Polymun Scientific ImmunbiologischeForschung GmbH
- Polypeptide Laboratories Inc
- Porton Fine Chemicals Ltd.
- Powdersize, Inc
- PrimaPharm, Inc.
- ProBioGen AG
- Procaps Group
- ProcosS.p.A.
- Provizer Pharma
- PureTek Corporation
- PX' Therapeutics
- QS Pharma LLC
- Quality Chemical Laboratories
- Quay Pharmaceuticals Limited
- R L Fine Chem
- R.p. Scherer GmbH & Co. KG
- R5
- Rablon
- Radico Remedies
- Recipharm
- Redwig Pharma
- Regis Technologies Inc.
- Reliable Biopharmaceutical Corporation
- Reliance Life Sciences
- Reliance Life Sciences Private Limited
- Relthy Laboratories
- RentschlerBiotechnologie GmbH
- Richter Helm Biologics GmbH and Co KG
- RIVOPHARM SA
- Roche
- Rolabo Outsourcing, S.L.
- Rottendorf Pharma GmbH
- ROVI Contract Manufacturing
- Rubicon Research Private Limited
- Rusan
- S.M. Pharmaceuticals
- SAFC Inc
- SAI Life Sciences
- Samsung Biologics
- Sandoz
- Sanico N.V.
- SanochemiaPharmazeutika AG
- Sanofi-Aventis
- Sanquin Pharmaceutical Servives
- Sartorius Stedium Biotech
- Sarvotham Care Ltd.
- SaviorLifetec Corporation
- SCI Pharmtech Inc.
- Scil Proteins
- ScinoPharm Pharmaceuticals, Ltd.
- SellasLifeSciences Group
- Selvok Pharmaceutical Co.
- Sentiss Pharma
- Shandong Xinhua Pharmaceutical Company Limited
- Shanghai Pharmaceutical IMP. & EXP. Co., Ltd.
- ShangPharma
- Sharon Bio-Medicine
- Shasun Pharmaceuticals Limited
- Shilpa Medicare Limited
- Siegfried
- Sigmapharm Laboratories, LLC
- Sirio Pharma
- SkyePharma
- Smruthi Organics
- SMS Pharmaceuticals Limited
- SocietaItalianaMedicinaliScandicci (S.I.M.S.) Srl
- Softigel
- Solitaire Pharmacia Pvt. Ltd.
- Sonar Products
- Sovereign Pharmaceuticals, LLC
- SRS Pharmaceuticals Pvt. Ltd.
- Stason Pharmaceuticals, Inc.
- Statens Serum Institut
- Sterigenics U.S., LLC
- Suir Pharma
- Summit Biosciences Inc
- Sunrise Pharmaceutical Inc
- Surya Pharmaceuticals
- Suven Life Sciences Limited
- Swedish orphan Biovitrum AB
- Synbias Pharma
- SynCo Bio Partners
- Syncom Healthcare limited
- Syngene (Subsidiary of Biocon)
- Synthokem Labs Private Limited
- Synthonics Inc
- Tai Heng Industry Co., Ltd.
- Taj Pharamceuticals limited
- Tapemark Company
- TAPI
- Tedor Pharma Inc.
- The Ritedose Corporation
- Theon Pharmaceuticals
- Therapure Biopharma Inc.
- Tianjin Pharmaceutical
- Time Cap Laboratories
- Titan Pharma Pvt. Ltd.
- Tokyo Chemical Industry Co., Ltd.
- Tolmar
- Torrent Pharmaceuticals Limited
- Toyobo Biologics, Inc.
- TygerScientificInc.
- UCB
- Ultratab Laboratories, Inc.
- Ultratech India Ltd.
- Uman Pharma Inc.
- UMN Pharma Inc.
- Unibiotech Formulations
- Unichem Laboratories Limited
- Unimark Remedies Limited
- University of Nebraska - Biological Process Development Facility
- UPM Pharmaceuticals
- UQUIFA
- US Pharma lab
- USV Limited
- Venturepharm Laboratories
- Vetcare
- Vetter Pharma
- VGXI Inc.
- Vibalogics
- Viropharm
- Vista Biologicals Corp.
- Visum Pharmaceutical Co., Ltd.
- Vital Health Care Pvt Ltd
- Vivante DMP Solutions
- VIVUS, Inc.
- VUAB Pharma
- Wacker Biotech GmbH
- WaismanBiomanufacturing
- Wanbury Limited
- WellSpring Pharmaceutical Corp.
- West-ward Pharmaceutical Corp (Subsidiary of Hikma PLC)
- Wilmington PharmaTech
- Windlas Biotech ltd.
- Windlas Healthcare Private Limited
- Wintac Limited
- Wisdom Pharmaceutical Co., Ltd.
- Wockhardt Limited
- WRAIR Pilot Bioproduction Facility
- WuXiAppTec Co. LTD.
- Xcelience, LLC
- Xellia Pharmaceuticals
- Xian Lijun Pharmaceutical
- Xttrium Laboratories, Inc.
- Yaopharma Co., Ltd.
- Yash Pharma Laboratories Pvt. Ltd.
- Yung Zip Chemical
- Zen Labs
- Zenara
- ZhejianHisun Pharma
- Zhejian HISUN Pharmaceuticals Co.
- Zhejiang ApeloaJiayuan Pharmaceutical Co., Ltd.
- Zhejiang Changming Pharmaceutical Co., Ltd.
- Zhejiang Cheng Yi Pharmaceutical Co., Ltd
- Zhejiang Excel Pharmaceutical Co., Ltd.
- Zhejiang Huahai Pharmaceutical
- Zhejiang JianfengHaizhou Pharmaceutical Co. Ltd.
- Zhejiang Jiang Yuan Tang Botechnology Co., Ltd.
- Zhejiang Jingxin
- Zhejiang Shenzhou Pharmaceutical Co., Ltd.
- Zydus BSV Pharma Private Limited

For more information visit http://www.researchandmarkets.com/research/lbq8h6/contract


CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Sector: Pharmaceuticals

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.